换一批Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation?
第一作者：
William V,Padula
第一单位：
Department of Pharmaceutical and Health Economics, Alfred E. Mann School of Pharmacy & Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA; Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA; Stage Analytics, Baltimore, MD, USA. Electronic address: padula@usc.edu.
作者：
医学主题词
人类(Humans);药费支出(Drug Costs);经济学, 药学(Economics, Pharmaceutical);Medicare(Medicare);谈判(Negotiating);质量校正寿命(Quality-Adjusted Life Years);技术评估, 生物医学(Technology Assessment, Biomedical);美国(United States)
DOI
10.1016/j.jval.2024.04.013
PMID
38677362
发布时间
2025-03-21
- 浏览0
Value in health
1100-1107页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
